← Leaderboards
Kevin Michael Kalinsky
Columbia University Health Sciences
$637,459
Attributed
$1,621,035
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $655.9K · FY2014–24$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,621,035 · 3
By mechanism
R01$1,311,435 · 1
R03$309,600 · 2
Top collaborators
- Konstantinos-Costas Arvanitis2 shared
- Gabriel A Kwong2 shared
- Graeme F Woodworth2 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Robert J Wechsler-Reya$14,668,725
- Ramon E Parsons$25,379,842
- Heath Pardoe$1,480,794
- Rakesh Sahni$1,147,279
- Abdullah M Ali$411,999
Others in their field
Top investigators on “Reporting”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Jeffrey P Krischer · University Of South Florida$564,567,727
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Bambra Strokes · Ppd Development Lp$461,655,950
- Mitchell J Malone · Texas A&M Research Foundation$344,583,004
- Gary D Acton · University Of California-Davis$320,373,312
Research focus
ReportingMalignant Breast NeoplasmMetastatic Breast CancerMigrationTherapeutic AgentsTumor TissueErbb2 GeneClinical TrialsDiagnosticMalignant NeoplasmsPreclinical StudyParticipantBreast Cancer CellStainsBrainCellsBaseClinically RelevantDiagnosisDoseTumorMagnetic Resonance ImagingStagingNeoplastic Cell
Grant awards (6)
Breast Cancer Brain Metastasis Therapy by Focused Ultrasound-Guided Control of HER2 CAR T cells$655,509
R01 · FY2024 · CA
Breast Cancer Brain Metastasis Therapy by Focused Ultrasound-Guided Control of HER2 CAR T cells$655,926
R01 · FY2023 · CA
Identifying leptomeningeal metastasis from breast cancer utilizing a novel immunocytochemical microfluidic device$80,000
R03 · FY2017 · CA · contact PI
Identifying leptomeningeal metastasis from breast cancer utilizing a novel immunocytochemical microfluidic device$80,000
R03 · FY2016 · CA · contact PI
Pre-Surgical trial of Metformin and Atorvastatin in Operable Breast Cancer$80,000
R03 · FY2015 · CA · contact PI
Pre-Surgical trial of Metformin and Atorvastatin in Operable Breast Cancer$69,600
R03 · FY2014 · CA · contact PI